Skip to content

Transmurale zorg Prostaatkanker, van diagnose tot en met nazorg

Transmural Care for Prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22953
Enrollment
200
Registered
2017-04-29
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer, transmural care, decision aid, SDM, Follow-up care, Substitution, Family doctors or General practitioners, Prostaatkanker, Keuzehulp, Samenwerking tussen eerste lijn en tweede lijn.

Interventions

1. Men who consider PSA testing will be counseled by their family doctor using a decision aid. These patients will be compared to men who receive usual care from their family doctor with regard to PS

Sponsors

Initiator: Catharina Wilhelmina Hospital (CWZ)Nijmegen Primary Sponsor/Performer: Radboud University Nijmegen Medical center Other performers: CWZ in Nijmegen, Maashospital Pantein in Boxmeer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy men who consider PSA testing. 2. Men who had prostatectomy for localized prostate cancer

Exclusion criteria

Exclusion criteria: Insufficient knowledge of the Dutch language.

Design outcomes

Primary

MeasureTime frame
Satisfaction of patients. Use of specialist care (Urology)

Secondary

MeasureTime frame
Patient knowledge Decisional conflict score Number of PSA tests ordered.

Contacts

Public ContactJulia van Tol-Geerdink

874 Radiation Oncology, Radboudumc, POBox 9101

julia.vantol-geerdink@radboudumc.nl024-3614515

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)